In a second , open-label , follow-up trial , adults entering from the 4-week study were titrated to an `` optimal '' LDX dose ( 30 mg/d [ n = 44 ] , 50 mg/d [ n = 112 ] , and 70 mg/d [ n = 171 ] ) over 4 weeks , and maintained for 11 additional months .
